vs
ARDELYX, INC.（ARDX）与AST SpaceMobile, Inc.（ASTS）财务数据对比。点击上方公司名可切换其他公司
ARDELYX, INC.的季度营收约是AST SpaceMobile, Inc.的1.7倍（$94.5M vs $54.3M），过去两年AST SpaceMobile, Inc.的营收复合增速更高（173.4% vs 13.6%）
Ardelyx是一家商业化阶段的生物制药企业，专注于研发和商业化针对胃肠道、心肾及代谢类疾病的创新疗法，其核心产品已在美国获批用于治疗便秘型肠易激综合征，同时拥有涵盖多适应症的各阶段研发管线。
AST SpaceMobile是总部位于美国得克萨斯州米德兰的上市卫星设计与制造企业，目前正搭建SpaceMobile卫星星座，打造可直接对接未改装普通智能手机的天基蜂窝宽带网络，面向全球偏远及通信服务薄弱地区提供4G、5G宽带覆盖服务。
ARDX vs ASTS — 直观对比
营收规模更大
ARDX
是对方的1.7倍
$54.3M
两年增速更快
ASTS
近两年复合增速
13.6%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $94.5M | $54.3M |
| 净利润 | $-37.6M | — |
| 毛利率 | — | — |
| 营业利润率 | — | -560.4% |
| 净利率 | -39.8% | — |
| 营收同比 | 27.5% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.15 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARDXASTS
| Q1 26 | $94.5M | $54.3M | ||
| Q4 25 | $125.2M | $54.3M | ||
| Q3 25 | $110.3M | $14.7M | ||
| Q2 25 | $97.7M | — | ||
| Q1 25 | $74.1M | — | ||
| Q4 24 | $116.1M | — | ||
| Q3 24 | $98.2M | — | ||
| Q2 24 | $73.2M | — |
净利润ARDXASTS
| Q1 26 | $-37.6M | — | ||
| Q4 25 | $-407.0K | $-74.0M | ||
| Q3 25 | $-969.0K | $-122.9M | ||
| Q2 25 | $-19.1M | — | ||
| Q1 25 | $-41.1M | — | ||
| Q4 24 | $4.6M | — | ||
| Q3 24 | $-809.0K | — | ||
| Q2 24 | $-16.5M | — |
毛利率ARDXASTS
| Q1 26 | — | — | ||
| Q4 25 | 91.3% | — | ||
| Q3 25 | 96.4% | — | ||
| Q2 25 | 87.3% | — | ||
| Q1 25 | 83.4% | — | ||
| Q4 24 | 84.3% | — | ||
| Q3 24 | 84.0% | — | ||
| Q2 24 | 87.1% | — |
营业利润率ARDXASTS
| Q1 26 | — | -560.4% | ||
| Q4 25 | 4.1% | -175.0% | ||
| Q3 25 | 4.2% | -1109.0% | ||
| Q2 25 | -14.7% | — | ||
| Q1 25 | -49.0% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | -18.6% | — |
净利率ARDXASTS
| Q1 26 | -39.8% | — | ||
| Q4 25 | -0.3% | -136.2% | ||
| Q3 25 | -0.9% | -833.7% | ||
| Q2 25 | -19.5% | — | ||
| Q1 25 | -55.5% | — | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | -0.8% | — | ||
| Q2 24 | -22.5% | — |
每股收益（稀释后）ARDXASTS
| Q1 26 | $-0.15 | — | ||
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.17 | — | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $0.00 | — | ||
| Q2 24 | $-0.07 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.1M | $2.3B |
| 总债务越低越好 | $203.5M | $12.0M |
| 股东权益账面价值 | $148.6M | $2.4B |
| 总资产 | $504.5M | $5.0B |
| 负债/权益比越低杠杆越低 | 1.37× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ARDXASTS
| Q1 26 | $238.1M | $2.3B | ||
| Q4 25 | $68.0M | $4.3B | ||
| Q3 25 | $42.7M | $2.4B | ||
| Q2 25 | $90.0M | — | ||
| Q1 25 | $30.8M | — | ||
| Q4 24 | $64.9M | — | ||
| Q3 24 | $47.4M | — | ||
| Q2 24 | $41.9M | — |
总债务ARDXASTS
| Q1 26 | $203.5M | $12.0M | ||
| Q4 25 | $202.8M | — | ||
| Q3 25 | $202.1M | — | ||
| Q2 25 | $201.4M | — | ||
| Q1 25 | $151.3M | — | ||
| Q4 24 | $150.9M | — | ||
| Q3 24 | $100.7M | — | ||
| Q2 24 | $100.2M | — |
股东权益ARDXASTS
| Q1 26 | $148.6M | $2.4B | ||
| Q4 25 | $166.9M | $2.4B | ||
| Q3 25 | $154.3M | $1.6B | ||
| Q2 25 | $139.5M | — | ||
| Q1 25 | $145.7M | — | ||
| Q4 24 | $173.3M | — | ||
| Q3 24 | $158.3M | — | ||
| Q2 24 | $147.0M | — |
总资产ARDXASTS
| Q1 26 | $504.5M | $5.0B | ||
| Q4 25 | $501.6M | $5.0B | ||
| Q3 25 | $486.2M | $2.6B | ||
| Q2 25 | $466.8M | — | ||
| Q1 25 | $410.2M | — | ||
| Q4 24 | $435.8M | — | ||
| Q3 24 | $367.9M | — | ||
| Q2 24 | $343.5M | — |
负债/权益比ARDXASTS
| Q1 26 | 1.37× | 0.01× | ||
| Q4 25 | 1.21× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 1.44× | — | ||
| Q1 25 | 1.04× | — | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARDX
| IBSRELA | $70.1M | 74% |
| XPHOZAH | $23.3M | 25% |
| Non-cash royalty revenue related to the sale of future royalties | $695.0K | 1% |
| Product supply revenue | $354.0K | 0% |
ASTS
暂无分部数据
